Atlas Trials

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

Clinical trial NCT05219916 · TERMINATED

Trial details

NCT number
NCT05219916
Sponsor
Hospices Civils de Lyon
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Human Immunodeficiency Virus I Infection
Start date
2022-04-12
Primary completion
2022-07-22
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.